top of page
gradientForSurfBreak.png

Item List

Yahoo
Invitae Launches Rare Patient Network for Pediatric Patients With Rare Neurodevelopmental Diseases

Invitae (NYSE: NVTA), a leading medical genetics company, today announced the launch of the Rare Patient Network expanding Invitae's Ciitizen platform to all patients with pediatric epilepsy and/or developmental delay with plans to include other conditions in the coming months. By engaging with a broader community, Invitae, a leader in the rare pediatric neurodevelopmental field, aims to create value for significantly more patients with rare diseases.

Recent Posts

Portfolio Company

Carlsmed.png

Regard and Kettering Health Hamilton Partner to Streamline EHR Navigation ...

PR Newswire

Portfolio Company

Carlsmed.png

Elektra Health Adds $3.3M in Seed Funding to Grow Its Platform for Evidence-base ...

FemTech Insider

Portfolio Company

Carlsmed.png

DeepScribe Launches New and Innovative Trust and Safety Suite for its Ambient AI ...

AIThority

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page